Abstract

Background and aimHemostasis profile is often complicated in liver cirrhosis. Thromboelastography is a global viscoelastic test recommended by the current practice guideline and consensus. This cross-sectional study aimed to evaluate the association of thromboelastography profile with severity of liver cirrhosis and presence of portal venous system thrombosis (PVST).MethodsOverall, 116 and 50 cirrhotic patients were included in the Shenyang and Xi’an cohorts, respectively. Thromboelastography parameters were compared between cirrhotic patients with Child–Pugh class A and B/C, those with and without decompensated events, and those with and without PVST. Hypercoagulability would be considered if at least two of the following thromboelastography parameters were met: shortened reactive time (R), shortened coagulation time (K), increased angle, and increased maximum amplitude (MA).ResultsIn the Shenyang cohort, 16 patients had shortened R, of whom seven (43.75%) had prolonged K and 11 (68.75%) decreased MA. In the Xi’an cohort, 24 patients had shortened R, of whom seven (29.17%) had prolonged K and 15 (62.50%) decreased MA. In the Shenyang cohort, the prevalence of hypercoagulability was not significantly different between cirrhotic patients with Child–Pugh class A and B/C (3.85% vs. 6.25%, P = 0.873), those with and without decompensated events (5.49% vs. 4.00%, P = 1.000), and those with and without PVST (4.17% vs. 5.88%, P = 1.000), which were similar to the results obtained in the Xi’an cohort.ConclusionThere is a high rate of discordance between R and other thromboelastography parameters. In addition, hypercoagulability may not be related to more advanced stage of liver cirrhosis or presence of PVST.

Highlights

  • Background and aimHemostasis profile is often complicated in liver cirrhosis

  • It has been believed that liver cirrhosis carries a high risk of bleeding and hypocoagulation indicated by the conventional coagulation tests (CCTs), such as prolonged prothrombin time (PT), higher international normalized ratio (INR), and lower platelet (PLT) count

  • We aimed to describe the hemostasis status by TEG in cirrhotic patients and to explore the correlation of hemostatic changes with the severity of liver cirrhosis and presence of portal venous system thrombosis (PVST)

Read more

Summary

Introduction

Thromboelastography is a global viscoelastic test recommended by the current practice guideline and consensus. This cross-sectional study aimed to evaluate the association of thromboelastography profile with severity of liver cirrhosis and presence of portal venous system thrombosis (PVST). CCTs could not reflect real-time global hemostasis status of patients with. He et al BMC Gastroenterol (2021) 21:253 cirrhosis [2, 4, 5]. We aimed to describe the hemostasis status by TEG in cirrhotic patients and to explore the correlation of hemostatic changes with the severity of liver cirrhosis and presence of portal venous system thrombosis (PVST) Thromboelastography (TEG) is a novel global viscoelastic test, and the current guidelines and consensus have stated that TEG can evaluate the status of hemostasis more comprehensively [6, 7].

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.